Document is current
Any future updates will be listed below
-
Authors
Breckenridge, J. P.
Gossage-Worrall, R.
Chadwick, P.
De Zoysa, N.
Elliott, J.
Gianfrancesco, C.
Hamilton, K.
Heller, S. https://orcid.org/0000-0002-2425-9565
Lawton, J.
Rankin, D.
Stanton-Fay, S.
Coates, E.
,
Beveridge, Susan
Friel, Elsie
Rogers, Helen
Amiel, Stephanie
Smith, Emma
Cooke, Debbie
Beckwith, Anita
Richardson, Liesl
Hopkins, David
Cox, Alison
Ferguson, Carolin
- License Information
-
More Information
Article History
Received: 30 December 2023
Accepted: 23 November 2024
First Online: 21 December 2024
Declarations
:
: Ethical approval was granted by the Usher Research Ethics Group at the University of Edinburgh (Ref 1732). Informed written consent from participants for all aspects of the study was confirmed.
: Covered in participation consent above.
: SH has served on speaker panels for Medtronic and NovoNordisk for which he has received remuneration. He has served on advisory panels or as a consultant for NovoNordisk, Eli Lilly, Zucara Pharmaceuticals and Zealand Pharma for which his institution has received remuneration. He is a co-investigator on a JDRF-funded project to develop and trial the DAFNEHART intervention now named ‘Beyond education: A Hypoglycaemia Awareness Restoration Program for people with type 1 diabetes and problematic hypoglycaemia persisting despite optimised self-care (HARPdoc).’ No other authors have competing interests to declare.
